2. Performance
The dynamic growth of the disposable bioreactor market is a response to the need for improved return on investment and technological productivity. This new concept is gradually making inroads, as conventional, low-modulability installations are gradually being replaced by single-use equipment that offers flexibility and reactivity, while maintaining quality and safety standards. Cultural barriers are undoubtedly the biggest obstacle between traditionalists and modernists, but an assessment of the advantages and disadvantages of this new equipment helps to weigh up the risks and objectify the choices
The Ultimate Scientific and Technical Reference
This article is included in
Bioprocesses and bioproductions
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Performance
Conclusion
Bibliography
Standards and norms
Biocompatibility standards
ISO 10993-5: Biological Evaluation of Medical Devices – In Vitro Cytotoxicity
US Pharmacopeia <87> : Biological Reactivity test, In Vitro
US Pharmacopeia <88> : Biological Reactivity Test, In Vivo
European Medicines Agency A410_01 (rev2) or European Pharmacopoeia 5.2.8 : Minimizing the Risk of...
Directory
Suppliers
Applikon
Cellexus
Celltainer
Eppendorf
Infors
Kuhner
Merck Millipore
New Brunswick
Pierre Guerin
Pall
Sartorius Stedim Biotech
Thermo...
Statistical and economic data
Market
The single-use bioreactor market was valued at €190.4 million in 2014, with expected growth of 18.4% a year to €424 million by 2019.
Bioprocessing news: Single-use bioreactor market to grow ALLpaQ Packaging Group January 29, 2015
Single-Use bioreactors for Pharma World market 2013-2023 Vision gain 03.06.2013
The Ultimate Scientific and Technical Reference
